NCT03713320 2022-04-08
SOLAR
miRagen Therapeutics, Inc.
Phase 2 Terminated
miRagen Therapeutics, Inc.
Yale University
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Peter MacCallum Cancer Centre, Australia
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center